@NEJMres360 Journal Club: Hosted by Royal Melbourne Hospital Internal Medicine Residency Program on A Multicenter Trial of Vena Cava Filters in Severely Injured Patients

Q&A begins
Authors
    • Intensive Care
    • Intensive Care Specialist, Deputy Director and Supervisor of Training in Intensive Care at Royal Perth Hospital

    Dr. Ho is a practising intensive care specialist, Deputy Director & Supervisor of Training in Intensive Care at Royal Perth Hospital. He obtained his medical degree (with distinction in Medicine) from the University of Hong Kong, Master in Public Health (with first-class Honour) from the University of Auckland, Postgraduate Diploma in Echocardiography from the University of Melbourne, and PhD from the University of Western Australia. Dr Ho is a fellow of the Royal College of Physicians of Glasgow (FRCP), Australian and New Zealand College of Anaesthetists (ANZCA), and College of Intensive Care Medicine of Australia and New Zealand (FCICM), and is a member of the American College of Epidemiology, Australian and New Zealand Society of Intensive Care (ANZICS), Australian Society of Anaesthetists (ASA), and Shock Society. He has published over 200 peer-reviewed manuscripts; his main research interests are thrombosis and hemostasis, prediction of outcomes, and acute kidney injury.

    • Neurological Surgery
    • Head of Department of Neurosurgery at Royal Perth Hospital

    Dr. Stephen Honeybul is a Consultant neurosurgeon at Sir Charles Gairdner Hospital and Head of Department of Neurosurgery at Royal Perth Hospital. A fellow of the Royal College of Surgeons of England, The Australasian college of Surgeons a member of the Neurological Society of Australasia and a member of the Neurosurgical Board of Australia and an Examiner for the FRACS in Neurosurgery. Current interests involve long term outcome and ethical issues regarding life saving but non restorative surgery following severe traumatic brain injury and ischaemic stroke.   

    • Hematology

    Ross Baker is Chairman of the Perth Blood Institute and Director of the Haemophilia Treatment Centre as well as a Senior Consultant Haematologist at the Hollywood Hospital. He currently is an Australian Councillor on the Asian Pacific Thrombosis and Haemostasis Society (ASPTH) and Chairman of the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ) new oral anticoagulant Reversal and Event Collaborative (ARES), Chairman of Asian Pacific Thrombosis and Thrombocytopenia Network (APTIN), the Prothrombotic Theme leader for the International Society of Thrombosis and Haemostasis Meeting in Melbourne 2019 and Co Chair of the von Willebrand Disorder Scientific Subcommittee of the International Society of Thrombosis and Haemostasis 2018-2020.